Transplant Rejection Treatment Market

Global Transplant Rejection Treatment Market Size, Trends, and Analysis - Forecasts To 2026 By Applications (Liver Transplant, Heart Transplant, Lung Transplant, Bone Marrow Transplant, Cornea Transplant, Others), By Treatment Type (Gene Therapy, Immunosuppressive Therapy, Antibody-based Therapy, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis

Category Healthcare
Format
  • ms word
  • ms excel
  • ms ppt
  • pdf
This report was recently updated on May 9 2022 with the latest and most recent market numbers

Transplant Rejection Treatment Market Size

The global transplant rejection treatment market is projected to grow from USD 5.6 billion in 2021 to USD 6.9 billion by 2026 at a CAGR value of 4.2% from 2021 to 2026. Increasing number of research and developmental activities related to transplant rejection procedure, increasing demand for transplant surgeries, rising chronic disease prevalence and high disposable income are some of the drivers supporting the growth of the market.

Technological advancements in the field of transplant procedure has helped various patients with chornic disorders recover faster. The introduction of organ transplant procedure in developed and developing countries is one of the most revolutionary developments in the medical space, and attained a considerable amount of acceptance and popularity globally.

However, while organ transplant has its own share of benefits, it also has the potential to negatively impact the immune system of the recipient due to which, organ transplant rejection medications have come under the spotlight. Immunologists and other stakeholders in the current value chain of the organ transplant rejection medications market are continually investing resources to assess the adaptive responses to solid organ transplantation.

COVID-19 pandemic has impacted the transplant rejection treatment market to a great extent as most of the hospitals had shifted their priority from planned surgeries to COVID-19 crisis management. Moreover, the hike in raw material prices and medical devices has also affected the market negatively. However, with the lockdown unlock norms, the market for transplant rejection treatment is expected to have a moderate growth rate.

global transplant rejection treatment market

Transplant Rejection Treatment Market: By Application 

Based on the application segment, the market is bifurcated into liver transplant, heart transplant, lung transplant, bone marrow transplant, cornea transplant, and others. According to the application analysis, the liver transplant segment is expected to dominate the segment with the highest market share during the forecast period. This is contributed because of rising prevalence of Hepatitis B and C, alcoholic liver disease, chronic coronary heart diseases, nonalcoholic fatty liver cirrhosis, genetic disorders, including hemochromatosis, Wilson's disease, primary biliary cirrhosis, primary sclerosing cholangitis, and biliary atresia. Biliary atresia is the most common reason for liver transplants among children too.

Transplant Rejection Treatment Market: By Treatment Type

Based on the treatment type, the transplant rejection treatment market is bifurcated into gene therapy, immunosuppressive therapy, antibody-based therapy, others. Gene therapy is the most commonly used technique by end users and hence is analyzed to be the fastest growing segment in the market. Gene therapy replaces a faulty gene or adds a new gene in an attempt to cure or improve the body's ability to fight disease.

Transplant Rejection Treatment Market: By Distribution Channel

Based on the distribution channel, the market is segment into hospital pharmacies, and retail pharmacies. The hospital pharmacies segment is expected to dominate with the highest market share during the forecast period. Hospitals pharmacies provide a wider range of treatments due to the availability of specialized staff and trained professionals.

asia pacific transplant rejection treatment market

Transplant Rejection Treatment Market: By Region

The regional analysis for the market of transplant rejection treatment is bifurcated into North America, Europe, Asia Pacific, Central & South America, and the Middle East & Africa.

North America is estimated to be the largest segment and Asia Pacific is analyzed to be the fastest growing region during the forecast period. Varied factors contribute to said growth of Asia Pacific which include rising health awareness and organ transplant procedures in counties like China and India, key development and investment programs for organ transplant and associated medical and pharmaceutical research in countries like Japan and South Korea, and government support and schemes in India to support liver transplant procedures.

Transplant Rejection Treatment Market Share & Competitor Analysis

Key players in the transplant rejection treatment market are Biogen Inc., Cell Source, Inc., Bellicum Pharmaceuticals, Inc., Capricor Therapeutics, Inc., Cleveland BioLabs, Inc., Fate Therapeutics, Inc., Cellect Biotechnology Ltd., F. Hoffmann-La Roche Ltd., Compugen Ltd., Escape Therapeutics, Inc., Cytodyn Inc among others.

Please note: This is not an exhaustive list of companies profiled in the report.

Chapter 1   Methodology

1.1    Market Scope & Definitions

1.2    Estimates & Forecast Calculation

1.3    Historical Data Overview and Validation

1.4    Data Sources

1.4.1    Secondary

1.4.2    Primary

Chapter 2   Report Outlook

2.1    Transplant Rejection Treatment Industry Overview, 2019-2026

2.1.1    Industry Overview

2.1.2    Application Overview

2.1.3    Treatment Type Overview

2.1.4    Distribution Channel Overview

2.1.6    Regional Overview

Chapter 3   Transplant Rejection Treatment Market Trends

3.1    Market Segmentation

3.2    Industry Background, 2019-2026

3.3    Market Key Trends

3.3.1    Positive Trends

3.3.1.1    Rising prevalence of liver and heart diseases

3.3.2    Industry Challenges

3.3.2.1    Lack of adequate infrastructure and transplant management set ups in developing nations

3.4    Prospective Growth Scenario

3.4.1    Application Growth Scenario

3.4.2    Treatment Type Growth Scenario

3.4.3    Distribution Channel Growth Scenario

3.5    COVID-19 Influence over Industry Growth

3.6    Porter’s Analysis

3.7    PESTEL Analysis

3.8    Value Chain & Supply Chain Analysis

3.9    Regulatory Framework

3.9.1    North America

3.9.2    Europe

3.9.3    APAC

3.9.4    LATAM

3.9.5    MEA

3.10    Distribution Channel Overview

3.11    Market Share Analysis, 2020

3.11.1    Company Positioning Overview, 2020

Chapter 4   Transplant Rejection Treatment Market, By Application

4.1    Application Outlook

4.2    Liver Transplant

4.2.1    Market Size, By Region, 2019-2026 (USD Billion)

4.3    Heart Transplant

4.3.1    Market Size, By Region, 2019-2026 (USD Billion)

4.4    Lung Transplant

4.4.1    Market Size, By Region, 2019-2026 (USD Billion)

4.5    Bone Marrow Transplant

4.5.1    Market Size, By Region, 2019-2026 (USD Billion)

4.6    Cornea Transplant

4.6.1    Market Size, By Region, 2019-2026 (USD Billion)

4.7    Others

4.7.1    Market Size, By Region, 2019-2026 (USD Billion)

Chapter 5   Transplant Rejection Treatment Market, By Treatment Type

5.1    Treatment Type Outlook

5.2   Gene Therapy

5.2.1    Market Size, By Region, 2019-2026 (USD Billion)

5.3    Immunosuppressive Therapy

5.3.1    Market Size, By Region, 2019-2026 (USD Billion)

5.4    Antibody-Based Therapy

5.4.1    Market Size, By Region, 2019-2026 (USD Billion)

5.5    Others

5.5.1    Market Size, By Region, 2019-2026 (USD Billion)

Chapter 6   Transplant Rejection Treatment Market, By Distribution Channel

6.1    Hospitals Pharmacies

6.1.1    Market Size, By Region, 2019-2026 (USD Billion)

6.2    Retail Pharmacies

6.2.1    Market Size, By Region, 2019-2026 (USD Billion)

Chapter 7   Transplant Rejection Treatment Market, By Region

7.1    Regional outlook

7.2    North America

7.2.1    Market Size, By Country 2019-2026 (USD Billion)

7.2.2    Market Size, By Application, 2019-2026 (USD Billion)

7.2.3    Market Size, By Treatment Type, 2019-2026 (USD Billion)

7.2.4    Market Size, By Distribution Channel, 2019-2026 (USD Billion)

7.2.6    U.S.

7.2.6.1    Market Size, By Application, 2019-2026 (USD Billion)

7.2.4.2    Market Size, By Treatment Type, 2019-2026 (USD Billion)

7.2.4.3    Market Size, By Distribution Channel, 2019-2026 (USD Billion)

7.2.7    Canada

7.2.7.1    Market Size, By Application, 2019-2026 (USD Billion)

7.2.7.2    Market Size, By Treatment Type, 2019-2026 (USD Billion)

7.2.7.3    Market Size, By Distribution Channel, 2019-2026 (USD Billion)

7.3    Europe

7.3.1    Market Size, By Country 2019-2026 (USD Billion)

7.3.2    Market Size, By Application, 2019-2026 (USD Billion)

7.3.3    Market Size, By Treatment Type, 2019-2026 (USD Billion)

7.3.4    Market Size, By Distribution Channel, 2019-2026 (USD Billion)

7.3.6    Germany

7.3.6.1    Market Size, By Application, 2019-2026 (USD Billion)

7.3.6.2    Market Size, By Treatment Type, 2019-2026 (USD Billion)

7.3.6.3    Market Size, By Distribution Channel, 2019-2026 (USD Billion)

7.3.7    UK

7.3.7.1    Market Size, By Application, 2019-2026 (USD Billion)

7.3.7.2    Market Size, By Treatment Type, 2019-2026 (USD Billion)

7.3.7.3    Market Size, By Distribution Channel, 2019-2026 (USD Billion)

7.3.8    France

7.3.7.1    Market Size, By Application, 2019-2026 (USD Billion)

7.3.7.2    Market Size, By Treatment Type, 2019-2026 (USD Billion)

7.3.7.3    Market Size, By Distribution Channel, 2019-2026 (USD Billion)

7.3.9    Italy

7.3.9.1    Market Size, By Application, 2019-2026 (USD Billion)

7.3.9.2    Market Size, By Treatment Type, 2019-2026 (USD Billion)

7.3.9.3    Market Size, By Distribution Channel, 2019-2026 (USD Billion)

7.3.10    Spain

7.3.10.1    Market Size, By Application, 2019-2026 (USD Billion)

7.3.10.2    Market Size, By Treatment Type, 2019-2026 (USD Billion)

7.3.10.3    Market Size, By Distribution Channel, 2019-2026 (USD Billion)

7.3.11    Russia

7.3.11.1    Market Size, By Application, 2019-2026 (USD Billion)

7.3.11.2    Market Size, By Treatment Type, 2019-2026 (USD Billion)

7.3.11.3    Market Size, By Distribution Channel, 2019-2026 (USD Billion)

7.4    Asia Pacific

7.4.1    Market Size, By Country 2019-2026 (USD Billion)

7.4.2    Market Size, By Application, 2019-2026 (USD Billion)

7.4.3    Market Size, By Treatment Type, 2019-2026 (USD Billion)

7.4.4    Market Size, By Distribution Channel, 2019-2026 (USD Billion)

7.4.6    China

7.4.6.1    Market Size, By Application, 2019-2026 (USD Billion)

7.4.6.2    Market Size, By Treatment Type, 2019-2026 (USD Billion)

7.4.6.3    Market Size, By Distribution Channel, 2019-2026 (USD Billion)

7.4.7    India

7.4.7.1    Market Size, By Application, 2019-2026 (USD Billion)

7.4.7.2    Market Size, By Treatment Type, 2019-2026 (USD Billion)

7.4.7.3    Market Size, By Distribution Channel, 2019-2026 (USD Billion)

7.4.8    Japan

7.4.7.1    Market Size, By Application, 2019-2026 (USD Billion)

7.4.7.2    Market Size, By Treatment Type, 2019-2026 (USD Billion)

7.4.7.3    Market Size, By Distribution Channel, 2019-2026 (USD Billion)

7.4.9    Australia

7.4.9.1    Market Size, By Application, 2019-2026 (USD Billion)

7.4.9.2    Market size, By Treatment Type, 2019-2026 (USD Billion)

7.4.9.3    Market Size, By Distribution Channel, 2019-2026 (USD Billion)

7.4.10    South Korea

7.4.10.1    Market Size, By Application, 2019-2026 (USD Billion)

7.4.10.2    Market Size, By Treatment Type, 2019-2026 (USD Billion)

7.4.10.3    Market Size, By Distribution Channel, 2019-2026 (USD Billion)

7.5    Latin America

7.5.1    Market Size, By Country 2019-2026 (USD Billion)

7.5.2    Market Size, By Application, 2019-2026 (USD Billion)

7.5.3    Market Size, By Treatment Type, 2019-2026 (USD Billion)

7.5.4   Market Size, By Distribution Channel, 2019-2026 (USD Billion)

7.5.6    Brazil

7.5.6.1    Market Size, By Application, 2019-2026 (USD Billion)

7.5.6.2    Market Size, By Treatment Type, 2019-2026 (USD Billion)

7.5.6.3    Market Size, By Distribution Channel, 2019-2026 (USD Billion)

7.5.7    Mexico

7.5.7.1    Market Size, By Application, 2019-2026 (USD Billion)

7.5.7.2    Market Size, By Treatment Type, 2019-2026 (USD Billion)

7.5.7.3    Market Size, By Distribution Channel, 2019-2026 (USD Billion)

7.5.8    Argentina

7.5.7.1    Market Size, By Application, 2019-2026 (USD Billion)

7.5.7.2    Market Size, By Treatment Type, 2019-2026 (USD Billion)

7.5.7.3    Market Size, By Distribution Channel, 2019-2026 (USD Billion)

7.6    MEA

7.6.1    Market Size, By Country 2019-2026 (USD Billion)

7.6.2    Market Size, By Application, 2019-2026 (USD Billion)

7.6.3    Market Size, By Treatment Type, 2019-2026 (USD Billion)

7.6.4    Market Size, By Distribution Channel, 2019-2026 (USD Billion)

7.6.6    Saudi Arabia

7.6.6.1    Market Size, By Application, 2019-2026 (USD Billion)

7.6.6.2    Market Size, By Treatment Type, 2019-2026 (USD Billion)

7.6.6.3   Market Size, By Distribution Channel, 2019-2026 (USD Billion)

7.6.7    UAE

7.6.7.1    Market Size, By Application, 2019-2026 (USD Billion)

7.6.7.2    Market Size, By Treatment Type, 2019-2026 (USD Billion)

7.6.7.3    Market Size, By Distribution Channel, 2019-2026 (USD Billion)

7.6.8    South Africa

7.6.7.1    Market Size, By Application, 2019-2026 (USD Billion)

7.6.7.2    Market Size, By Treatment Type, 2019-2026 (USD Billion)

7.6.7.3    Market Size, By Distribution Channel, 2019-2026 (USD Billion)

Chapter 8   Company Landscape

8.1    Competitive Analysis, 2020

8.2    Biogen Inc.

8.2.1    Company Overview

8.2.2    Financial Analysis

8.2.3    Strategic Positioning

8.2.4    Info Graphic Analysis

8.3    Cell Source, Inc.

8.3.1    Company Overview

8.3.2    Financial Analysis

8.3.3    Strategic Positioning

8.3.4    Info Graphic Analysis

8.4    Bellicum Pharmaceuticals, Inc.

8.4.1    Company Overview

8.4.2    Financial Analysis

8.4.3    Strategic Positioning

8.4.4    Info Graphic Analysis

8.5    Capricor Therapeutics, Inc.

8.5.1    Company Overview

8.5.2    Financial Analysis

8.5.3    Strategic Positioning

8.5.4    Info Graphic Analysis

8.6    Cleveland BioLabs, Inc.

8.6.1    Company Overview

8.6.2    Financial Analysis

8.6.3    Strategic Positioning

8.6.4    Info Graphic Analysis

8.7    Fate Therapeutics, Inc.

8.7.1    Company Overview

8.7.2    Financial Analysis

8.7.3    Strategic Positioning

8.7.4    Info Graphic Analysis

8.8    Cellect Biotechnology Ltd.

8.8.1    Company Overview

8.8.2    Financial Analysis

8.8.3    Strategic Positioning

8.8.4    Info Graphic Analysis

8.9    F. Hoffmann-La Roche Ltd.

8.8.1    Company Overview

8.8.2    Financial Analysis

8.8.3    Strategic Positioning

8.8.4    Info Graphic Analysis

8.10    Compugen Ltd.

8.10.1    Company Overview

8.10.2    Financial Analysis

8.10.3    Strategic Positioning

8.10.4    Info Graphic Analysis

8.11    Other Companies

8.11.1    Company Overview

8.11.2    Financial Analysis

8.11.3    Strategic Positioning

8.11.4    Info Graphic Analysis

The Global Transplant Rejection Treatment Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Transplant Rejection Treatment Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

We value your investment and offer free customization with every report to fulfil your exact research needs.
This website is secure and your personal details are safe. Privacy

Frequently Asked Questions

The global transplant rejection treatment market is projected to grow from USD 5.6 billion in 2021 to USD 6.9 billion by 2026 at a CAGR value of 4.2% from 2021 to 2026.
Key players in the transplant rejection treatment market are Biogen Inc., Cell Source, Inc., Bellicum Pharmaceuticals, Inc., Capricor Therapeutics, Inc., Cleveland BioLabs, Inc., Fate Therapeutics, Inc., Cellect Biotechnology Ltd.., F. Hoffmann-La Roche Ltd., Compugen Ltd., Escape Therapeutics, Inc., and Cytodyn Inc among others.
The APAC region is estimated to hold the largest share of the transplant rejection treatment market.
COVID-19 pandemic has impacted the transplant rejection treatment market to a great extent as most of the hospitals had shifted their priority from planned surgeries to COVID-19 crisis management. Moreover, the hike in raw material prices and medical devices has also affected the market negatively. However, with the lockdown unlock norms, the market for transplant rejection treatment is expected to have a moderate growth rate.
Increasing number of research and developmental activities related to transplant rejection procedure, increasing demand for transplant surgeries, rising chronic disease prevalence and high disposable income are some of the drivers supporting the growth of the market.

Tailor made solutions just for you

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

OUR CLIENTS

  • Client of Global Market Estimates - Fedex
  • Client of Global Market Estimates - Samsung
  • Client of Global Market Estimates - Siemens
  • Client of Global Market Estimates - Lonza
  • Client of Global Market Estimates - DuPont
  • Client of Global Market Estimates - Medtronic
  • Client of Global Market Estimates - Toray
  • Client of Global Market Estimates - Signify
  • Client of Global Market Estimates - Teledyne
  • Client of Global Market Estimates - Trelleborg
  • Client of Global Market Estimates - Kikkoman Biochemifa
  • Client of Global Market Estimates - Leoni
  • Client of Global Market Estimates - Molnlycke
  • Client of Global Market Estimates - Spirent
  • Client of Global Market Estimates - Tokyo Electron Limited
  • Client of Global Market Estimates - Aranca
  • Client of Global Market Estimates - Asahi Kasei
  • Client of Global Market Estimates - Chimai
  • Client of Global Market Estimates - Grapsud
  • Client of Global Market Estimates - Horiba
  • Client of Global Market Estimates - Indorama
  • Client of Global Market Estimates - L&T
  • Client of Global Market Estimates - Integralife
  • Client of Global Market Estimates - Synamedia
  • Client of Global Market Estimates - Sorrento Therapeutics
  • Client of Global Market Estimates - Solenis
  • Client of Global Market Estimates - Sartorius